Katerina Anokhina

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

AstraZeneca (United States)(Current)

Heidelberg University

University Hospital Heidelberg

Alexion Pharmaceuticals (United States)

Hôpital Tenon

Katerina Anokhina is an author at AstraZeneca (United States) specializing in complement dysregulation, kidney transplantation, and renal pathophysiology.

ORCID

Publications per year

2022–2024

Publications

Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry

Jean‐Michel Halimi, Imad Al‐Dakkak, Katerina Anokhina et al. · Journal of Nephrology · 2022 · 26 citations · Full text

Medicine, Hematology, Internal Medicine +10

Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab

Franz Schaefer, Imad Al‐Dakkak, Katerina Anokhina et al. · Kidney International Reports · 2024 · 13 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Characterization of patients with <scp>aHUS</scp> and associated triggers or clinical conditions: A Global <scp>aHUS</scp> Registry analysis

Christoph Licht, Imad Al‐Dakkak, Katerina Anokhina et al. · Nephrology · 2024 · 11 citations · Full text

Medicine, Hematology, Internal Medicine +16

1–3 of 3